Skip to main content

Table 2 Comparison of plasma Urotensin-II levels according to demographic and clinical variables

From: Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines

Demographic and clinical variables

Urotensin (pg/ml)

  
 

Migraine

Control

p value

Smoking

1.15 ± 0.51

0.99 ± 0.52

0.003*

Non-smoking

1.104 ± 0.6

0.82 ± 0.61

0.001*

p value

0.965

0.854

 

Female

1.19 ± 0.48

0.96 ± 0.62

0.001*

Male

0.98 ± 0.45

0.84 ± 0.48

0.003*

p value

0.185

0.832

 

Drugs (+)

1,13 ± 0.4

-

 

Drugs (–)

1,11 ± 0.51

-

 

p value

0,981

  

Vomiting (+)

1.21 ± 0.6

  

Vomiting (–)

1.04 ± 0.51

  

p value

0.004*

  

FF (+)

1.19 ± 0.5

  

FF (-)

1.17 ± 0.6

  

p value

0.967

  

Mood (+)

1.28 ± 0.7

  

Mood (-)

0.99 ± 0.6

  

p value

0.001*

  
  1. Valuables are expressed as the mean ± SD
  2. Drug (+): Using symtomatic migraine drugs
  3. Drug (-): Not using symptomatic migraine drugs
  4. FF photophobia and phonophobia
  5. *p < 0.05